$4.29
-0.17-3.81%
At close: -
$4.50
0.214.90%
After Hours: Jan 31, 8:00 AM EDT
Alto Neuroscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Alto Neuroscience using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.62 | $-0.64 | 3.12 % |
Q2 | 2024-08-13 | $-0.60 | $-0.63 | 4.76 % |
Q1 | 2024-05-14 | $-0.76 | $-0.46 | -65.2 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Alto Neuroscience (ANRO) is scheduled to report earnings on February 14, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.62, which beat the estimate of $-0.64.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.